These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21880252)

  • 1. [TIF1γ: a tumor suppressor gene in chronic myelomonocytic leukemia].
    Aucagne R; Droin N; Solary E; Bastie JN; Delva L
    Med Sci (Paris); 2011; 27(8-9):696-8. PubMed ID: 21880252
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia.
    Aucagne R; Droin N; Paggetti J; Lagrange B; Largeot A; Hammann A; Bataille A; Martin L; Yan KP; Fenaux P; Losson R; Solary E; Bastie JN; Delva L
    J Clin Invest; 2011 Jun; 121(6):2361-70. PubMed ID: 21537084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TIF1γ is a chief conductor of the hematopoietic system].
    Kusy S; Roméo PH
    Med Sci (Paris); 2011; 27(8-9):698-700. PubMed ID: 21880253
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders.
    Miles DK; Freedman MH; Stephens K; Pallavicini M; Sievers EL; Weaver M; Grunberger T; Thompson P; Shannon KM
    Blood; 1996 Dec; 88(11):4314-20. PubMed ID: 8943868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell interactions and gene expression in early hematopoiesis.
    Gordon MY; Ford AM; Greaves MF
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():11-24; discussion 24-5. PubMed ID: 2324553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.
    Tessema M; Länger F; Bock O; Seltsam A; Metzig K; Hasemeier B; Kreipe H; Lehmann U
    Int J Oncol; 2005 Feb; 26(2):499-507. PubMed ID: 15645136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mzf1 controls cell proliferation and tumorigenesis.
    Gaboli M; Kotsi PA; Gurrieri C; Cattoretti G; Ronchetti S; Cordon-Cardo C; Broxmeyer HE; Hromas R; Pandolfi PP
    Genes Dev; 2001 Jul; 15(13):1625-30. PubMed ID: 11445537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia stem cells.
    Testa U
    Ann Hematol; 2011 Mar; 90(3):245-71. PubMed ID: 21107841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.
    Yu L; Liu C; Vandeusen J; Becknell B; Dai Z; Wu YZ; Raval A; Liu TH; Ding W; Mao C; Liu S; Smith LT; Lee S; Rassenti L; Marcucci G; Byrd J; Caligiuri MA; Plass C
    Nat Genet; 2005 Mar; 37(3):265-74. PubMed ID: 15723065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
    Robb L; Begley CG
    Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of haematopoiesis.
    Göttgens B
    Vox Sang; 2004 Jul; 87 Suppl1():15-9. PubMed ID: 15200597
    [No Abstract]   [Full Text] [Related]  

  • 15. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
    Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
    Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-DDX10 and DDX10-NUP98 fusion transcripts.
    Ikeda T; Ikeda K; Sasaki K; Kawakami K; Takahara J
    Int J Hematol; 1999 Apr; 69(3):160-4. PubMed ID: 10222653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression.
    Ganapati U; Tan HT; Lynch M; Dolezal M; de Vos S; Gasson JC
    Stem Cells; 2007 Aug; 25(8):1872-80. PubMed ID: 17464091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIC1 hypermethylation is a late event in hematopoietic neoplasms.
    Issa JP; Zehnbauer BA; Kaufmann SH; Biel MA; Baylin SB
    Cancer Res; 1997 May; 57(9):1678-81. PubMed ID: 9135007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.